Candesartan vs Rituximab

## Candesartan vs Rituximab: Overview

This comparison examines the pharmacological differences between **Candesartan** and **Rituximab**.

## Mechanism of Action

**Candesartan**: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Candesartan — 9 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Candesartan — C33H34N6O6; Rituximab — N/A.

**Molecular Weight**: Candesartan — 610.6640 g/mol; Rituximab — N/A.

**Type**: Candesartan — Small molecule; Rituximab — Antibody.